Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02684500 · ClinicalTrials.gov registry record

Aneurysmal Subarachnoid Hemorrhage and Superior Mesenteric Artery Flow Study

A clinical trial of Intracranial Aneurysm, sponsored by University of Florida.

Completed
Registry status
14
Enrollment target
1
Study location

NCT02684500: Completed study of Intracranial Aneurysm, sponsored by University of Florida.

NCT02684500 is a study of Intracranial Aneurysm that has completed, run by University of Florida. The registered enrollment target is 14 participants, below the 9,195-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02684500, a study of Intracranial Aneurysm, has completed, sponsored by University of Florida.

COMPLETED
Registry status
14 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to determine if the diameter and flow of the superior mesenteric artery in patients with aneurysmal subarachnoid hemorrhage undergoing hypertensive therapy for cerebral artery vasospasm are effected enough to justify withholding enteral nutrition.

Conditions Studied

Interventions

  • DEVICE Ultrasound

Study Locations (1)

Florida

  • UF Health - Gainesville

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2016-04-11
Est. Completion 2016-06-30
University of Florida

1,106 total trials

What the finished NCT02684500 record still lists

NCT02684500 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 9,195-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.

NCT02684500 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02684500 about?

NCT02684500 is a clinical study titled "Aneurysmal Subarachnoid Hemorrhage and Superior Mesenteric Artery Flow Study". The purpose of this research study is to determine if the diameter and flow of the superior mesenteric artery in patients with aneurysmal subarachnoid hemorrhage undergoing hypertensive therapy for cerebral artery vasospasm are effected enough to justify withholding enteral nutrition.

What is the current status of trial NCT02684500?

This trial is currently completed. The enrollment target is 14 participants. The study started on 2016-04-11. Estimated completion is 2016-06-30.

What conditions does trial NCT02684500 study?

This clinical trial studies the following conditions: Intracranial Aneurysm.

What interventions are being tested in trial NCT02684500?

The interventions under investigation include: Ultrasound (DEVICE).

Who is sponsoring clinical trial NCT02684500?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02684500 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intracranial Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02684500's enrollment target sits among peer trials

14 15th of 14 the lowest of 14 other Intracranial Aneurysm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Intracranial Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT02684500, the US trial registry maintained by the National Library of Medicine. NCT02684500 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.